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Abstract 
 
Purpose: In 2007 the Dutch Surgical Society published a clinical practice guideline for the 
treatment of hip fracture patients, based on the best available international evidence at that 
time. We investigated to what extent treatment of femoral neck fracture patients in the 
Netherlands corresponded with these guidelines, and determined differences in patient 
characteristics between the treatment groups.  
Methods: All femoral neck fracture patients treated in 14 hospitals between February 2008 
and August 2009 were included. Patient characteristics, X-rays, and treatment data were 
collected retrospectively.  
Results: From a total of 1250 included patients 59% had been treated with arthroplasty, 39% 
with internal fixation, and 2% with a non-operative treatment. While 74% of the treatment 
choices complied with the guideline, 12% did not. In 14% adherence could not be determined 
from the available data. Arthroplasty was preferred over internal fixation in elderly patients 
with severe comorbidity, pre-fracture osteoporosis and a displaced fracture, that were 
ambulatory with aids pre-fracture (Odds Ratio, OR 2.2-58.1). Sliding hip screws were 
preferred over cancellous screws in displaced fractures (OR 1.9).  
Conclusions: Overall guideline adherence was good. Most deviations concerned treatment of 
elderly patients with a displaced fracture, as well as implant use in internal fixation. 
Additional data, preferably with a higher scientific level of evidence, on these issues is needed 
in order to improve the guideline and to reinforce a more uniform treatment of these patients.
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Introduction 
 
Hip fractures are associated with 30% mortality at one year and a profound temporary, 
sometimes permanent impairment of independence and quality of life [1]. Worldwide, 4.5 
million people are disabled of hip fractures yearly, with an expected increase to 21 million 
persons living with a disability by 2040 [2, 3]. Approximately 50% of all hip fractures are 
intracapsular fractures of the femoral neck [4]. These can be treated with a non-operative 
treatment, internal fixation or arthroplasty. 
 In 2007 the Dutch Surgical Society (NVvH) published a guideline on the treatment of 
hip fracture patients [5]. This guideline provides a decision tree for the treatment of femoral 
neck fracture patients (Figure 1). Decisions are based upon evidence-based patient and 
fracture characteristics, that are relevant in the Netherlands as well as internationally [4, 6-
12]. The guideline reflects surgical guidelines and behavior in Europe, although the English 
guideline is more detailed, specially concerning arthroplasty [13]. 
 There is consensus that patients with undisplaced fractures should be treated with 
internal fixation [4]. Surgeons also agree that femoral neck fracture patients with arthrosis, 
rheumatoid arthritis, or a pathologic fracture should be treated with arthroplasty, as these 
conditions are contraindications for internal fixation. Surgeons agree that elderly (i.e., >80 
years old) with a displaced fracture should receive arthroplasty as well. 
 There is no clear consensus on the treatment of younger patients with a displaced 
fracture [6, 7, 9, 10, 14-16]. From meta-analyses it is known that internal fixation may lead to 
lower infection rates, less blood loss, a shorter operative time, and possibly a decrease in 
mortality rate. In contrast, arthroplasty significantly reduces the revision surgery rate [9, 10, 
17]. Therefore, it is generally recommended that internal fixation can be used in patients with 
limited comorbidity and a low ASA-score (American Society of Anaesthesiologists), who are 
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mobile, independent, and not cognitively disabled pre-fracture. Patients for whom the risk of 
revision surgery is considered too high should be treated with arthroplasty. 
 After arthroplasty or internal fixation has been decided on, the type of prosthesis (i.e., 
hemi-arthroplasty or total hip arthroplasty) or internal fixation (most commonly sliding hip 
screw or cancellous screws) has to be selected. Again, there is no consensus and surgical 
preference may play a role [6, 18-22]. 
 In summary, for some patient groups there is still a need to define if they will benefit 
from a specific treatment [10]. The guideline provided the best available evidence when 
developed in 2007. As it cannot provide level I evidence for all patients, we anticipated that 
surgeons may differ in their treatment of some patient subgroups. 
 The aim of this study was to determine the extent to which femoral neck fracture 
patients were treated in agreement with the national guideline. As the guideline states that 
treatment decision should be based upon patient and fracture characteristics, differences in 
these characteristics between the treatment groups were also determined. 
 4 
 5 
Patients and Methods 
 
Fourteen hospitals participated in this retrospective study. These sites participated in a 
multicenter randomized controlled trial, the FAITH trial (Fixation using Alternative Implants 
for the Treatment of Hip fractures, NCT00761813) and formed a femoral neck fracture 
research network. This network consists of general/trauma surgeons and orthopedic surgeons 
in four academic hospitals and ten large non-academic hospitals, as both treat femoral neck 
fractures in the Netherlands. 
 All consecutive femoral neck fracture patients treated in these hospitals between 
February 2008 and August 2009 were included. Patients who had been referred to another 
hospital were excluded. Patients were identified by searching the electronic hospital database 
for DBC-code (Diagnose Behandel Combinatie; Diagnosis Related Groups (DRG’s)), ICD-
codes (International Classification of Diseases, version 9/10), and surgical codes. The 
following data were collected: 
- patient characteristics: age, gender, ASA-score, comorbidity (e.g., dementia, arthrosis, 
malignancies, and cardiac and pulmonary disease), pre-fracture living status, pre-fracture use 
of aids, and additional injuries; 
- fracture characteristics: Garden (i.e., undisplaced versus displaced) and Pauwels (i.e., 1-2 
versus 3) classification; 
- treatment: type of treatment, surgical delay, surgeon’s specialization, quality of reduction 
and positioning of the implant in internal fixation, and FAITH-participation; 
 Fracture characteristics were assessed independently by two senior trauma surgeons 
(MJH and MHJV) from blinded preoperative, peroperative, and postoperative X-rays. They 
also assessed the quality of reduction and positioning of implants used using criteria as 
defined in the Dutch NVvH guidelines (Table 1). If two out of three criteria were met, 
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reduction and positioning were scored as ‘acceptable’. If the assessment was indecisive, a 
third trauma surgeon (GRR) independently reviewed the X-rays and reached a final decision. 
 
Statistical Analysis 
Analyses were performed using SPSS (version 16.0, SPSS Inc., Chicago, IL, USA).  
In order to perform a quantitative analysis of the degree of guideline adherence, we identified 
the patient subgroups for whom the guideline gives a clear, unambiguous treatment advice 
(level 1-3). For each patient group with a guideline based treatment proposal (a, b,…, z), the 
total number of patients in this group were counted (na, nb,…, nz). Subsequently, the number 
of patients who actually received the proposed treatment were counted (ya, yb,…, yz). The 
proportion of provided treatments that corresponded with the guideline recommendations was 
calculated using the formula: ((ya+ yb+ …+ yz) /(na+ nb,…+ nz)) x 100%. 
 Using similar calculations, the proportion of treatments for which adherence was 
unclear was reported. Guideline adherence was considered unclear if the treatment seemed in 
contradiction with the guideline, but could have been explained by a patient characteristic that 
was not collected in this study (e.g., coxarthrosis or a pathological fracture). 
 Different treatment groups were compared; non-operative versus operative treatment, 
internal fixation versus arthroplasty, cancellous screws versus sliding hip screw, and hemi-
arthroplasty versus total hip arthroplasty.  
 Continuous variables are presented as medians with interquartile ranges, categorical 
variables as numbers and percentage. Continuous variables were compared using the Mann-
Whitney U-test. Categorical variables were compared using the Chi-squared test. A P-value 
<0.05 (two-sided) was taken as threshold of statistical significance. A multivariable logistical 
regression analysis using a forward stepwise approach was performed in order to model the 
relation between patient and fracture characteristics, and the treatment group. Variables that 
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displayed a P-value <0.1 in univariate analyses and variables which are likely to influence 
outcome were entered as covariate. 
 From this study population 194 patients also participated in the FAITH trial. They 
were randomized between a treatment with sliding hip screw or cancellous screws. Entering 
‘FAITH participation’ as covariate into the regression model had no statistically significant 
effect on the results. The FAITH patients were therefore not excluded from analyses. 
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Results 
 
Demographic description of patient, fracture and treatment characteristics 
A total of 1355 femoral neck fracture patients were identified. Pre-operative or post-operative 
X-rays could not be retrieved for 105 patients; these were therefore excluded. The remaining 
1250 patients were studied; 22 patients (2%) had been treated with a non-operative treatment, 
486 (39%) with internal fixation, and 742 (59%) with arthroplasty. Of the internal fixation 
patients 290 (60%) had been treated with cancellous screws (CS) and 196 (40%) with a 
sliding hip screw (SHS). Of the arthroplasty patients 731 (99%) had been treated with a hemi-
arthroplasty (HA) and 11 (1%) with a total hip arthroplasty (THA).  
 Non-operatively treated patients were significantly more often demented, had more 
often undisplaced fractures, and less often Pauwels 3 fractures, than surgically treated 
patients. Internal fixation patients were in a better condition than arthroplasty patients; 
younger, lower ASA-scores, had lower rates of comorbidity, known osteoporosis, medication 
use, dementia, and pre-fracture aided mobility, and a higher rate of independent living pre-
fracture. Internal fixation patients were also less likely to have displaced fractures and 
Pauwels 3 fractures (Table 2). 
 Within the internal fixation group the SHS group was significantly older than the CS 
group, more often demented, and had more often known arthrosis (in other joints). 
Nevertheless, fewer SHS patients lived independently pre-fracture. In contrast, the CS group 
had lower ASA-scores, was less likely to have rheumatoid arthritis and osteoporosis, and had 
displaced fractures more often. 
 Within the arthroplasty group the THA patients were in a better condition than the HA 
patients. They were significantly younger, had lower rates of dementia, medication use, or 
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pre-fracture aided mobility. However, they had a higher rate of arthrosis and osteoporosis pre-
fracture. 
 Treatment characteristics were also compared (Table 2). There were differences in the 
treatment received in academic hospitals (compared with non-academic hospitals) and in the 
treatment performed by general/trauma surgeons (compared with orthopedic surgeons). 
 
Guideline adherence 
Figure 2 shows the patient numbers in the different treatment groups. We identified the 
patient groups for whom the guideline gives a clear, unambiguous treatment advice. 
 Undisplaced fractures should be treated either with internal fixation or non-
operatively. Of 322 patients with an undisplaced fracture, 247 had been treated with internal 
fixation, 59 with arthroplasty, and 16 non-operatively. 
 Patients with a displaced fracture should receive internal fixation if they are 65-80 
years, ambulatory and have an ASA-score<3. These characteristics were present in 195 
patients, 79 of whom had been treated with internal fixation, and 116 with an arthroplasty. 
Patients with a displaced fracture aged 65-80, who have an ASA-score>2 should receive an 
arthroplasty. Of 82 patients with these characteristics, 64 had been treated accordingly, and 18 
had been treated with internal fixation. Arthroplasty should also be performed in patients aged 
>80 years with a displaced fracture. Of 511 patients with these characteristics, 465 were 
treated with an arthroplasty, 42 with internal fixation and four with a non-operative treatment. 
 If internal fixation is chosen for a Pauwels 3 fracture, the guideline recommends using 
a SHS. Of 171 Pauwels 3 internally fixated fractures, 77 received SHS and 94 CS. 
 In conclusion, of all treatments that could be quantitatively analyzed for guideline 
adherence, 74% corresponded with the guideline (Calculation: 
((247+16+79+64+465+77)/(322+195+82+511+171))*100%). In 26% the treatment deviated 
 9 
 10 
from the guideline. However, in 13% it could not be determined whether the treatment choice 
could have been explained by a characteristic that was not collected in this study (e.g., 
coxarthrosis or a pathological fracture). In addition, 37 internal fixation patients with an 
unacceptable reduction were not converted to arthroplasty, and 45 internal fixation patients 
had an unacceptable implant position. In total, 72 internal fixation patients did not receive an 
acceptable treatment (15%). 
 
Differences in characteristics between the treatment groups 
Patient and fracture characteristics that independently influenced the treatment decision were 
studied using multivariable logistic regression models. Compared with internal fixation, 
patients had a greater chance of receiving an arthroplasty if they were older, had severe 
comorbidity (ASA-score>2) or osteoporosis diagnosed pre-fracture, a displaced fracture, were 
mobile pre-fracture using an aid, or if they had been treated by an orthopedic surgeon (Odds 
Ratio (OR) 2.2-58.1, Table 3). Patients receiving an arthroplasty were more often aged >80 
years and had a higher odds of displaced fractures (OR 51.8 and 58.1, Table 3).  
In internal fixation patients, a SHS was preferred over CS in patients with displaced 
fractures (OR 1.9; 95% CI 1.1-3.1, P=0.021), if they were treated in an academic hospital (OR 
2.4; 95% CI 1.0-5.7, P=0.041). CS were preferred by orthopedic surgeons (OR 0.4, 95% CI 
0.1-0.9, P=0.037). 
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Discussion 
 
Guideline adherence 
Overall guideline adherence was considered well, as 74% of the treatments corresponded. 
Deviations mainly concerned the treatment of elderly patients with a displaced fracture. 
Although the guideline recommends arthroplasty for patients aged 65-80 years with a 
displaced fracture and severe comorbidity (i.e., ASA score>2), 22% of these patients were 
treated with internal fixation. In an international survey 6-26% of the surgeons preferred 
internal fixation for these patients as well [6]. In addition, 8% of patients aged >80 years with 
a displaced fracture were treated with internal fixation, whereas the guideline advises 
arthroplasty. The lack of convincing, irrefutable evidence on the treatment of these patient 
subgroups is reflected in our results [6, 7, 14]. A second reason for treatment inconsistency 
could be the shifting age limit for internal fixation of elderly with displaced fractures in the 
last decade. Traditionally, an age of 65-75 years was considered a fixed limit for using 
internal fixation. Now it has progressed to 80 years (in fit, healthy patients). Finally, some 
surgeons feel that internal fixation should be an acute treatment in all patients. A secondary 
arthroplasty, if necessary, can then be performed in a planned setting. This strategy may 
reduce the revision surgery, as the patients condition can be optimized pre-operatively. 
 Although the guideline suggests the use of sliding hip screws for Pauwels 3 fractures, 
53% of these fractures in our study were treated with cancellous screws. Clearly, there is no 
agreement on implant selection for the treatment of sheer fractures. Since surgeons were not 
interviewed we do not know how many surgeons used the Pauwels classification in their 
decision making. 
  
Patient and fracture characteristics 
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Our data showed that characteristics that surgeons consider when deciding on a treatment are 
age and fracture displacement in particular, but also comorbidity, pre-fracture diagnosed 
osteoporosis and pre-fracture mobility. These characteristics are compliant with the guideline 
[8, 17, 23]. Other characteristics that should be considered are dementia and pre-fracture 
living status [8, 9, 11, 23, 24]. These characteristics did not influence treatment in this study. 
 Orthopedic surgeons favored arthroplasty more often than general/trauma surgeons 
did. Orthopedic surgeons may have more affinity with arthroplasty, as they perform 
arthroplasties more often (e.g., for arthrosis). Moreover, in the Netherlands total hip 
arthroplasties are performed by orthopedic surgeons only. Although it is comprehensible to 
perform a treatment that one is comfortable with, patient outcome should come first. 
Likewise, the treatment should not differ between academic and non-academic hospitals. 
 
The strength of this study is the inclusion of a large, representative population. Participating 
surgeons represent both orthopedic and trauma/general surgeons in academic and non-
academic hospitals in five different trauma regions nationwide. The guideline that was 
studied, is based on the best available international evidence at the time of development, and 
is therefore applicable internationally. Our results may stimulate others to perform similar 
research, as there are no guideline adherence studies concerning hip fracture treatment 
available at this moment, to the best of our knowledge. 
Obviously, this study has limitations. The retrospective nature made it difficult to 
collect data on some characteristics that probably affected treatment decision (e.g., 
pathological fracture, osteoarthrosis, or rheumatoid arthritis). However, as these 
characteristics are considered absolute contraindications for internal fixation, we expect that 
all surgeons provided the indicated treatment in these specific patients. A second limitation is 
the Pauwels classification assessment. It is known that the inter-observer agreement of the 
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Pauwels classification on pre-operative X-rays is low [25]. All X-rays were assessed in 
duplicate in order to obtain the highest reliability possible. Finally, there was unfortunately no 
option to question the surgeons about their motivation to deviate from the guideline. 
 
In summary, overall adherence to the guideline for femoral neck fracture treatment was good, 
as 74% of the treatments corresponded. Most deviations concerned the treatment of elderly 
(age 65-80 years and >80 years) with a displaced fracture, and the implant choice in internal 
fixation. Additional data, preferably with a higher scientific level of evidence is needed in 
order to improve the guideline and to reinforce a more uniform treatment of these patients 
[10].
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Tables 
 
 
Table 1. Criteria for acceptable reduction and positioning of the implant for internal 
fixation of a femoral neck fracture, according to Dutch NVvH guideline (5) 
 
Acceptable reduction Varus-valgus dislocation: maximum Garden index: 160–180° + 
Femoral neck shortening neutralized+ 
Dorsoventral dislocation: maximum 10° retroversion - 5° anteversion++ 
Acceptable position 
cancellous screws 
 
One screw placed caudally over the calcar femoris+ 
One screw placed over the dorsal cortex++ 
Screws positioned into the subchondral bone (maximum distance 
between screw tip and femoral head lining: 5-10 mm)+ 
Acceptable position 
sliding hip screw 
Screw positioned in the central or caudal 1/3 part of femoral head+ 
Screw positioned in the central or dorsal part of femoral head++ 
Screw positioned into the subchondral bone (maximum distance between 
screw tip and femoral head lining: 5-10 mm)+ 
+ On AP (Anterior-Posterior) view. ++ On axial view.
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Table 2. Patient, fracture, and treatment characteristics 
 
 Total 
N=1250 
Non-
operative* 
N=22 
IF** 
N=486 
Arthroplasty 
N=742 
CS*** 
N=290 
SHS 
N=196 
HA**** 
N=731 
THA 
N=11 
Age1 (years) 81 (72-87) 81 (70-89) 72 (60-81) D 84 (79-88) 75 (62-84) D 68 (56-78) 85 (80-88) D 62 (51-77) 
Gender2 (female) 804 (64) 18 (82) 264 (54) D 522 (70) 159 (55) 105 (54) 517 (71) 5 (46) 
ASA-score2 (ASA>2) 383 (31) 11 (50) 59 (12) D 313 (42) 33 (11) A 26 (13) 309 (42) 4 (36) 
Comorbidity2 959 (77) 16 (73) 316 (65) D 627 (85) 186 (64) 130 (66) 618 (85) 9 (82) 
Pulmonary disease2 124 (10) 2 (9) 48 (10) 74 (10) 29 (10) B 19 (10) 74 (10) 0 (0) 
Cardiac disease2 329 (26) 3 (14) 104 (21) C 222 (30) 70 (24) C 34 (17) 222 (30) A 0 (0) 
Hypertension2 303 (24) 3 (14) 96 (20) B 204 (28) 49 (17) C 47 (24) 201 (28) 3 (27) 
Diabetes2 153 (12) 1 (5) 51 (11) 101 (14) 34 (12) C 17 (9) 101 (14) 0 (0) 
CVA/TIA2 176 (14) 3 (14) 52 (11) 121 (16) 30 (10) B 22 (11) 121 (17) 0 (0) 
Malignancy (past and present)2 184 (15) 5 (23) 61 (486) A 118 (16) 36 (12) B 25 (13) 117 (16) 1 (9) 
Dementia2 238 (19) 9 (41) A 42 (9) D 187 (25) 31 (11) B 11 (6) 187 (26) A 0 (0) 
Arthrosis pre-fracture2 67 (5) 1 (5) 20 (4) 46 (6) 13 (5) B 7 (4) 43 (6) C 3 (27) 
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Rheumatoid arthritis2 35 (3) 0 (0) 12 (3) 23 (3) 5 (2) C 7 (4) 23 (3) 0 (0) 
Osteoporosis pre-fracture2 77 (6) 1 (5) 22 (5) A 54 (7) 11 (4) A 11 (6) 50 (7) D 4 (26) 
Medication2 921 (74) 17 (77) 311 (64) D 593 (80) 183 (63) 128 (65) 588 (80) C 5 (46) 
Additional injuries2 61 (5) 1 (5) 29 (6) 31 (4) 18 (6) 11 (6) 31 (4) 0 (0) 
Pre-fracture living status2 
(independent)§§ 
No data available 
700 (56) 
 
263 (21) 
12 (55) 
 
2 (9) 
362 (75) 
 
62 (13) D 
326 (44) 
 
199 (27) 
204 (70) 
 
45 (16) A 
158 (81) 
 
17 (9) 
320 (44) 
 
195 (27) 
6 (55) 
 
4 (36) 
Pre-fracture use of aids2 
No data available 
171 (14) 
766 (61) 
5 (23) 
13 (59) 
39 (8) 
232 (48) D 
127 (17) 
521 (70) 
24 (8) 
148 (51) 
15 (8) 
84 (43) 
127 (17) 
514 (70) A 
0 (0) 
7 (64) 
Garden classification2 (displaced) 927 (74) 6 (27) D 239 (49) D 682 (92) 124 (43) C 115 (59) 673 (92) 9 (82) 
Pauwels classification2 (Pauwels 3) 492 (39) 3 (14) A 171 (35) D 318 (43) 94 (32) 77 (39) 312 (43) 6 (55) 
Hospital2 (academic)§ 154 (12) 6 (27) A 71 (15) A 77 (10) 31 (11) C 40 (20) 73 (10) C 4 (36) 
Surgical delay1 (days) 1 (0-1) N.A. 1 (0-1) D 1 (0-1) 1 (0-1) 1 (0-1) 1 (0-1) A 2 (1-6) 
Surgeon2 (general or trauma)§§ 1005 (80) 19 (86) D 425 (87) D 561 (76) 242 (83) C 183 (93) 561 (77) D 0 (0) 
Surgery performed by2 (resident)§§§ 775 (62) N.A 347 (71) D 428 (58) 217 (75) 130 (66) 426 (58) A 2 (18) 
Reduction2 (unacceptable) N.A. N.A. 37 (8) N.A. 28 (10) A 9 (5) N.A. N.A. 
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Positioning implant2 (unacceptable) N.A. N.A. 45 (9) N.A. 27 (9) 18 (9) N.A. N.A. 
IF, Internal Fixation; CS, Cancellous screws; SHS, Sliding Hip Screw; HA, Hemi-Arthroplasty; THA, Total Hip Arthroplasty; CVA, Cerebro 
Vascular Accident; TIA, Transient Ischemic Attack; N.A., Not applicable 
Unavailable data are only presented for variables that had ≥10% unavailable data in any group. Exception: in the THA group data were missing 
in two patients (18%) for all variables concerning comorbidity. 
* P-values are presented for the comparison of non-operative therapy with surgery. ** P-values are presented for the comparison of internal 
fixation with arthroplasty. *** P-values are presented for the comparison of CS with SHS. **** P-values are presented for the comparison of HA 
with THA. 
A P<0.05, B P<0.01, C P<0.005, D P<0.001. Non-significant P-values are not presented. The Mann-Whitney U-test was used for continuous 
variables, the Chi-squared test for categorical variables. 
1 Data are presented as median with P25-P75 given between brackets. 2 Data are presented as number with percentages. 
§ As opposed to non-academic hospital. §§ As opposed to orthopaedic surgeon. §§§ As opposed to surgeon. However, >80% of these operations 
were supervised by a surgeon. 
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Table 3. Odds Ratios for the relation between patient and fracture characteristics, and 
choice of treatment: internal fixation versus arthroplasty 
 
Determinant  Odds Ratio (95% 
CI) 
P-value 
Age group 0-65 years 
66-80 years 
81-100 years 
Reference 
5.6 (2.5-12.8) 
51.8 (18.9-142.2) 
 
<0.001 
<0.001 
ASA score ASA 1-2 
ASA 3-4 
Reference 
7.4 (3.0-18.4) 
 
<0.001 
Osteoporosis pre-fracture No 
Yes 
Reference 
3.1 (1.0-9.6) 
 
0.045 
Pre-fracture mobility No aids 
Using aids 
Reference 
2.2 (1.0-4.7) 
 
0.048 
Garden classification Garden 1-2 (undisplaced) 
Garden 3-4 (displaced) 
Reference 
58.1 (20.9-161.2) 
 
<0.001 
Surgeon General or trauma 
Orthopaedic 
Reference 
4.2 (1.8-10.1) 
 
0.001 
Multivariable logistic regression model, using a forward stepwise approach. 
An Odds Ratio>1.0 implies a greater chance of receiving arthroplasty.  
Variables not included in the final model were hospital type, gender, arthrosis pre-fracture, 
rheumatoid arthritis, dementia, medication, pre-fracture living status, and Pauwels 
classification. 
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Figures 
 
 
Figure 1. Decision tree for the treatment of hip fracture patients, from the NVvH richtlijn: 
Behandeling van de proximale femurfractuur bij de oudere mens (Guideline: Treatment of the 
proximal femoral fracture in the elderly person) [5] 
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Figure 2. Decision tree for the treatment of femoral neck fracture patients, from the NVvH 
richtlijn: Behandeling van de proximale femurfractuur bij de oudere mens (Guideline: 
Treatment of the proximal femoral fracture in the elderly person) [5]. Patient numbers are 
shown.  
* Garden classification could not be determined for one patient. **Pauwels classification 
could not be determined for eight patients. The decision tree could not be completed for these 
patients. 
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